Skip to main content

Novo Nordisk

 

Clinical courses

 

Clinical courses

  • Novo Nordisk is looking for Marketing Executive - B.Pharm/B.Sc

    Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

    Post: Marketing Executive

  • Vacancy for CRA/Trainee Clinical Research Associate in Novo Nordisk

  • Job as Safety Data Analyst in Novo Nordisk

    Novo nordisk's data management department was established in Bangalore, India in the month of September 2007 and has significantly grown from 10 members to a strong team of over 140 Clinical Data Management professionals. It has witnessed significant transformations right from providing DM services to IO region reporting to IOCDC to becoming an integral part of Global development from Aug 2010. It is a young, enthusiastic and dynamic team with varied skillsets and professionals from diverse backgrounds such as pharmacy, life-sciences, physiotherapy, computer / information sciences and business administration.

    Post: Safety Data Analyst

  • Work as Patent Information Specialist in Novo Nordisk

    Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

    Post: Patent Information Specialist

  • Opportunity for Clinical Data Manager in Novo Nordisk

    Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

    Post: Clinical Data Manager

  • Work as RA Associate III in Novo Nordisk

    Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

    Post: RA Associate III

  • Job as Business Development Manager in Novo Nordisk

    Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

    Post: Business Development Manager

  • Opening for B.Pharm/B.Sc as Trainee Business Executive - Bio pharm in Novo Nordisk

    Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

    Post: Trainee Business Executive - Bio pharm

  • Last week 7.8 magnitude earthquake hit Nepal. In response to this Novo Nordisk India has shared  donation of  75,000 insulin vials to the Indian government’s relief operations. The insulin valued at Rs.1 crore. This is to support people with diabetes who have been affected by the earthquake and who currently need access to this life saving medication. As damage and destruction has made living in Nepal citizens, people with diabetes in Nepal are facing difficulty to get medications.

  • Novo Nordisk, a world leader in insulin and diabetes care,  has launched Saxenda (liraglutide 3 mg), the first glucagon-like peptide-1 (GLP-1) receptor agonist the United States.  Saxenda is a drug used to treat obesity.  Saxenda has approved in the US, EU and Canada.

Subscribe to Novo Nordisk